『MEDCast』のカバーアート

MEDCast

MEDCast

著者： MJH Life Sciences
無料で聴く

MEDCast is a healthcare program brought to you by HCPLive.com that features leading medical experts who discuss a range topic within a particular condition or medical disorder.© 博物学 生物科学 科学 自然・生態学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • 13: Enfortumab Vedotin and the Evolving Landscape of Bladder Cancer Care: A Pharmacist’s Guide to ADCs, Combination Therapy, and Expanding Clinical Engagement

    13: Enfortumab Vedotin and the Evolving Landscape of Bladder Cancer Care: A Pharmacist’s Guide to ADCs, Combination Therapy, and Expanding Clinical Engagement
    2026/05/19
    A landscape overview of enfortumab vedotin’s expanding role across bladder cancer settings — from MIBC to earlier lines of therapy — with a focus on pharmacist-led patient support, AE management, and real-world implementation.
    続きを読む 一部表示
    51 分
  • 10: Clinical Approaches for Treatment Intensification in Metastatic Castration-Sensitive Prostate Cancer

    10: Clinical Approaches for Treatment Intensification in Metastatic Castration-Sensitive Prostate Cancer
    2026/05/01
    This episode reviews treatment intensification in metastatic castration-sensitive prostate cancer, focusing on why ADT plus an ARPI is the current backbone of care, what barriers still limit its use, and how clinicians think about triplet therapy, de-intensification, frail patients, and emerging biomarker-driven options such as PARP inhibitors.
    続きを読む 一部表示
    34 分
  • 9: Indirect Trial Comparisons in Metastatic Castration-Sensitive Prostate Cancer

    9: Indirect Trial Comparisons in Metastatic Castration-Sensitive Prostate Cancer
    2026/05/01
    This episode examines how indirect trial comparisons can help guide ARPI selection in metastatic castration-sensitive prostate cancer when head-to-head studies are unavailable, while emphasizing the importance of patient-specific factors, tolerability, and clinical judgment.
    続きを読む 一部表示
    34 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません